|
Volumn 43, Issue 9, 2002, Pages 1795-1801
|
Bleomycin, epidoxorubicin, cyclophosphamide, vincristine and prednisone (BACOP) in patients with follicular non-Hodgkin's lymphoma: Results of a prospective, multicenter study of the Gruppo Italiano per lo Studio dei Linfomi (GISL)
a b c d e f g a c b a e f f b
e
Ospedale Civile
(Italy)
|
Author keywords
Anthracycline; BACOP; Chemotherapy; Follicular lymphoma; NHL
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
EPIRUBICIN;
PREDNISONE;
VINCRISTINE;
ADULT;
ADVANCED CANCER;
AGED;
ARTICLE;
BONE MARROW METASTASIS;
CANCER COMBINATION CHEMOTHERAPY;
CANCER RECURRENCE;
CANCER REGISTRY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
FEMALE;
FOLLICULAR LYMPHOMA;
FOLLOW UP;
HEMATOLOGIC DISEASE;
HUMAN;
ITALY;
MAJOR CLINICAL STUDY;
MALE;
MINIMAL RESIDUAL DISEASE;
MULTICENTER STUDY;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
SCORING SYSTEM;
SURVIVAL RATE;
TREATMENT OUTCOME;
VALIDATION PROCESS;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BLEOMYCIN;
CYCLOPHOSPHAMIDE;
DISEASE-FREE SURVIVAL;
DOXORUBICIN;
FEMALE;
HUMANS;
ITALY;
LYMPHOMA, NON-HODGKIN;
MALE;
MIDDLE AGED;
PREDNISONE;
PROGNOSIS;
PROSPECTIVE STUDIES;
RISK FACTORS;
TIME FACTORS;
TREATMENT OUTCOME;
VINCRISTINE;
|
EID: 6444244551
PISSN: 10428194
EISSN: None
Source Type: Journal
DOI: 10.1080/1042819021000006457 Document Type: Article |
Times cited : (7)
|
References (27)
|